A COST-CONSEQUENCE ANALYSIS OF PONATINIB VERSUS IMATINIB IN PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN THE UNITED STATES

被引：0
|
作者：
Hernandez, L. G. [1 ]
Davies, S. [2 ]
Li, C. [3 ]
Reddick, L. E. [1 ]
Jensen, I [2 ]
机构：
[1] Takeda Pharmaceut Amer Inc, Lexington, MA USA
[2] PRECISIONheor, Precis Value & Hlth, Boston, MA USA
[3] Takeda Dev Ctr Amer Inc, Lexington, MA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE165
引用
收藏
页码：S88 / S88
页数：1
相关论文
共 50 条
  • [31] Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
    Yinjun Lou
    Yafang Ma
    Chenyin Li
    Sansan Suo
    Hongyan Tong
    Wenbin Qian
    Wenyuan Mai
    Haitao Meng
    Wenjuan Yu
    Liping Mao
    Juyin Wei
    Weilei Xu
    Jie Jin
    Frontiers of Medicine, 2017, 11 : 229 - 238
  • [32] Quality-Adjusted Time without Symptoms of Disease or Toxicity (Q-TWiST) of Ponatinib Versus Imatinib, Administered in Combination with Reduced-Intensity Chemotherapy, in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Ashaye, Ajibade
    Shi, Ling
    Aldoss, Ibrahim
    Montesinos, Pau
    Vachhani, Pankit
    Papayannidis, Cristina
    Leonard, Jessica T.
    Baer, Maria R.
    Ribera, Josep-Maria
    Mccloskey, James
    Wang, Jianxiang
    Gao, Sujun
    Rane, Deepali
    Guo, Shien
    BLOOD, 2024, 144 : 2825 - 2826
  • [33] Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
    Lou, Yinjun
    Ma, Yafang
    Li, Chenyin
    Suo, Sansan
    Tong, Hongyan
    Qian, Wenbin
    Mai, Wenyuan
    Meng, Haitao
    Yu, Wenjuan
    Mao, Liping
    Wei, Juyin
    Xu, Weilei
    Jin, Jie
    FRONTIERS OF MEDICINE, 2017, 11 (02) : 229 - 238
  • [34] A randomized trial of imatinib versus chemotherapy induction followed by concurrent imatinib and chemotherapy as first-line treatment in elderly patients with de novo Philadelphia-positive acute lymphoblastic leukemia.
    Ottmann, OG
    Wassmann, B
    Goekbuget, N
    Scheuring, UJ
    Pfeifer, H
    Binckebanck, A
    Reutzel, R
    Giagounidis, A
    Sellmann, L
    Troll, K
    Gerecke, U
    Horst, HA
    Planker, M
    Stelljes, M
    Claus, B
    Matylis, A
    Kohlhammer, H
    Gschaidmeier, H
    Hoelzer, D
    BLOOD, 2003, 102 (11) : 226A - 226A
  • [35] Impact of the addition of rituximab in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
    Rios-Olais, Fausto Alfredo
    Rodriguez-Rodriguez, Sergio
    Mora-Canas, Analy
    Ramos-Penafiel, Christian Omar
    Urbalejo-Ceniceros, Victor Itai
    Lopez-Garcia, Yadith Karina
    Gomez-De Leon, Andres
    Delgado-Lopez, Nancy
    Castellanos-Mares, Mistral
    Figueroa-Hernandez, Patricia Carolina
    Demichelis-Gomez, Roberta
    LEUKEMIA & LYMPHOMA, 2025, 66 (03) : 561 - 564
  • [36] Imatinib in combination with chemotherapy for newly diagnosed BCR/ABL-positive acute lymphoblastic leukemia in adults
    Ohno, R.
    Yanada, M.
    Naoe, T.
    ANNALS OF HEMATOLOGY, 2006, 85 : 84 - 86
  • [37] Concurrent combination of high dose imatinib and dose-intensive chemotherapy for patients with newly diagnosed Philadelphia-positive acute lymphoblastic leukemia: Promising preliminary results of JALSG Ph+ALL202 study.
    Usui, N
    Towatari, M
    Yanada, M
    Takeuchi, J
    Yagasaki, F
    Takeshita, A
    Sugiura, I
    Takeuchi, M
    Ohno, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 567S - 567S
  • [38] CHARACTERISTICS OF PONATINIB THERAPY FOR PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH plus ALL) PATIENTS IN REAL-WORLD CLINICAL PRACTICE COMPARED TO THE PACE TRIAL
    Mauro, M.
    McGarry, L. J.
    Yang, M.
    Lustgarten, S.
    Huang, H.
    HAEMATOLOGICA, 2016, 101 : 355 - 355
  • [39] Long-Term Follow-up of Continuous Imatinib Plus Combination Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Lim, Sung-Nam
    Lee, Kyoo-Hyung
    Kim, Dae-Young
    Lee, Je-Hwan
    Lee, Jung-Hee
    Chi, Hyun-Sook
    Joo, Young-Don
    Lee, Won Sik
    Lee, Sang Min
    Park, Seonyang
    Kim, Inho
    Sohn, Sang Kyun
    Moon, Joon Ho
    Ryoo, Hun-Mo
    Bae, Sung Hwa
    Kim, Min Kyoung
    Yang, Deok-Hwan
    Eom, Hyeon-Seok
    Lee, Gyeong-Won
    Jung, Chul Won
    Won, Jong-Ho
    Kim, Hawk
    Lee, Jae-Hoon
    Shin, Ho-Jin
    Kim, Ho Young
    Hyun, Myung Soo
    Kim, Hyeoung Joon
    BLOOD, 2014, 124 (21)
  • [40] MOLECULAR ANALYSIS OF CHROMOSOME-22 BREAKPOINTS IN ADULT PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA
    KURZROCK, R
    SHTALRID, M
    GUTTERMAN, JU
    KOLLER, CA
    WALTERS, R
    TRUJILLO, JM
    TALPAZ, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1987, 67 (01) : 55 - 59
12345